People news

Share this article:
MANUFACTURERS
UCB
has appointed Mark McDade, executive vice president, global operations. He succeeds Bill Robinson, who will retire December 31, 2008.

Somnus Therapeutics, a private specialty pharmaceutical company focused on insomnia treatments, has announced the initial four members of its board of directors: Gary Cupit, CEO; Linda Hogan, chief business officer; David Ramsay, partner, Care Capital; and Jack Britts, president and CEO, Merz Pharmaceuticals.

AGENCIES
Media buying agency Compas has promoted Nicole Woodland-DeVan, formerly executive director, promotional purchasing, to vice president, beyond branding.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters